Can California Opioid Ruling Help Manufacturers In Pending Cases?
Judge’s dismissal of all claims against opioid makers offers hope they can win other cases and may push forward settlements. But it is ‘bookend’ by the Oklahoma case that reached a dramatically divergent conclusion, so while significant, it is only a single data point, Stanford law professor says.
You may also be interested in...
J&J and distributors have enough participation from states and subdivisions to move forward with $26bn settlement. The deal, the second largest in US history, may provide a framework for other companies to reach similar agreements. Jury trials remain pending in several states.
New York jury finds that Teva and distributor Anda violated state’s public nuisance law in their marketing and distribution of opioids. Such claims had been rejected by two previous courts and the verdict in this case shows the challenges companies face in ongoing litigation.
Show depicts former agency officials approving OxyContin labeling that enabled Purdue to market it as nonaddictive and subsequently refusing pleas to restrict its use.